Full length articleAssociations among plasma metabolite levels and short-term exposure to PM2.5 and ozone in a cardiac catheterization cohort
Introduction
Exposure to ambient air pollution affects a range of cardiovascular events (Brook et al., 2010, Rückerl et al., 2011). Acute (day-to-day) exposure to particulate matter (PM) with an aerodynamic diameter < 2.5 μm (PM2.5) is associated with increased risk of cardiovascular mortality, myocardial infarction, heart failure exacerbation, stroke (Atkinson et al., 2014, Mustafic et al., 2012, Shah et al., 2013, Shah et al., 2015) and induction of a variety of adverse cardiovascular outcomes (Brook et al., 2010, McGuinn et al., 2015). Epidemiological and controlled-exposure studies also suggest that exposure to ambient ozone may increase cardiovascular morbidity (Arjomandi et al., 2015, Devlin et al., 2012, Green et al., 2016, Hampel et al., 2012, Lanzinger et al., 2014). The elderly and those with underlying diseases, for example, cardiovascular diseases or diabetes, are particularly susceptible to the health effects of PM2.5 (Lanzinger et al., 2014, Rückerl et al., 2011, Shumake et al., 2013, Stafoggia et al., 2010); however, current evidence for the risks of ozone are inconclusive (Goodman et al., 2014).
The physiological mechanisms linking PM2.5 exposure to cardiovascular disease have yet to be fully elucidated. Biological pathways thought to be important include: systemic inflammation; changes in the autonomic balance; local inflammatory response; and oxidative stress due to translocation of particles or particle constituents (Brook et al., 2010, Peters et al., 2011). Further, inhalation of ozone may cause systemic inflammation and autonomic dysfunction (Brook et al., 2010, Devlin et al., 2012, Hampel et al., 2012). However, exploring the possibility that PM2.5- or ozone-induced changes in metabolic pathways may contribute to or mediate cardiometabolic outcomes is becoming increasing important for understanding potential mechanisms of these effects.
Metabolomics, or metabolomic profiling, refers to the comprehensive analysis of metabolites - low molecular weight chemicals including sugars, acylcarnitines, amino acids, and lipids - present in biological specimens (Rhee and Gerszten, 2012). Metabolomics has the potential for identifying novel biomarkers contributing to the onset or progression of cardiovascular disease (Shah et al., 2012a). Specific metabolomic profiles are associated with coronary artery disease (CAD) and atherosclerosis, and with major adverse cardiovascular events, including myocardial infarction, stroke, heart failure and death (Kordalewska and Markuszewski, 2015, Shah et al., 2012a, Würtz et al., 2015).
Current literature on short-term exposures to air pollution and blood chemistries has focused on traditional clinical parameters such as C-reactive protein or cytokines (e.g. Chuang et al., 2007, Rückerl et al., 2007, Tsai et al., 2012). However, evaluating associations between air pollution and metabolite levels could provide further evidence of air pollution-related physiologic changes and offer further insights into the pathophysiologic mechanisms by which short-term exposures to air pollution may increase the risk of acute cardiovascular events. So far, there has been only one epidemiological study exploring the association between air pollution and changes in metabolite levels (Menni et al., 2015). In this study using a subset of the TwinsUK cohort, long-term exposures to PM10 and PM2.5 were linked with metabolites related to reduced lung function. Only a small number of animal or toxicological studies have reported associations between inhaled toxicants and metabolite levels (Miller et al., 2015, Miller et al., 2016, Wang et al., 2012, Wang et al., 2015, Wei et al., 2013).
This study aimed to explore the influence of short-term exposures to PM2.5 and ozone on selected metabolites in a cohort of individuals undergoing cardiac catheterization for suspected CAD. Moreover, we evaluated whether these associations were modified by participant or lifestyle characteristics. Since the study population was at high risk for cardiovascular disease, our findings may help to uncover and clarify air pollution-metabolomics associations in a population particularly susceptible to the health effects of air pollution.
Section snippets
Study population
This study was conducted using data from the CATHeterization GENetics (CATHGEN) cohort, a large cohort of patients undergoing cardiac catheterization for suspected cardiovascular disease between 2001 and 2010 at the Duke University Cardiac Catheterization Clinic (Durham, NC)(Kraus et al., 2015).
For each of these patients, home addresses were extracted from medical records. Addresses were geocoded within the Children's Environmental Health Initiative (http://cehi.snre.umich.edu/), adding
Participant characteristics
Table 1 describes the study population. On average, participants were 59 years old with a mean BMI of 30 kg/m2. About 58% of the participants were men; approximately half were current smokers. The prevalence of CAD and hypertension was 50.4% and 67.9%, respectively; this reflects a population with increased risk for CAD.
Cluster analysis
Twenty-three of the 61 metabolites met all the inclusion criteria. Results of the cluster analysis are shown in Fig. 1. Most of the indices used to determine the relevant number
Summary
Prior day (1-day lag) increases in PM2.5 were associated with decreases in the concentrations of the amino acids arginine and glycine; PM2.5 was also associated with delayed increases in ornithine and C16:1. Increases in short-term exposures to ozone resulted in immediate and delayed increases of the amino acids aspartic acid/asparagine and ornithine; delayed increases were found for the acylcarnitines C10:1 and C16:1 as well as for total ketones. Results also suggested that there was effect
Disclaimer
Research described in this article was conducted under contract to the Health Effects Institute (HEI), and organization jointly funded by the United States Environmental Protection Agency (EPA) (Assistance Award No. R-82811201), and certain motor vehicle and engine manufacturers. The contents of this article do not necessarily reflect the views of HEI, or its sponsors, nor do they necessarily reflect the view and policies of the EPA or motor vehicle and engine manufacturers.
This work was
References (56)
- et al.
Race, socioeconomic status, and air pollution exposure in North Carolina
Environ. Res.
(2013) - et al.
Metabolomics in cardiovascular diseases
J. Pharm. Biomed. Anal.
(2015) - et al.
The impact of decreases in air temperature and increases in ozone on markers of endothelial function in individuals having type-2 diabetes
Environ. Res.
(2014) - et al.
Inhaled ozone (O3)-induces changes in serum metabolomic and liver transcriptomic profiles in rats
Toxicol. Appl. Pharmacol.
(2015) - et al.
A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance
Cell Metab.
(2009) - et al.
Metabolomics signature improves the prediction of cardiovascular events in elderly subjects
Atherosclerosis
(2014) - et al.
Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome
Lancet Diab. Endocrinol.
(2014) - et al.
Global association of air pollution and heart failure: a systematic review and meta-analysis
Lancet
(2013) - et al.
Arginine bioavailability ratios are associated with cardiovascular mortality in patients referred to coronary angiography
Atherosclerosis
(2011) - et al.
Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk
J. Am. Coll. Cardiol.
(2009)
Exposure to medium and high ambient levels of ozone causes adverse systemic inflammatory and cardiac autonomic effects
Am. J. Physiol. Heart Circ. Physiol.
Epidemiological time series studies of PM2.5 and daily mortality and hospital admissions: a systematic review and meta-analysis
Thorax
A bivariate space-time downscaler under space and time misalignment
Ann. Appl. Stat.
A spatio-temporal downscaler for output from numerical models
J. Agric. Biol. Environ. Stat.
Space-time data fusion under error in computer model output: an application to modeling air quality
Biometrics
Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association
Circulation
NbClust: an R package for determining the relevant number of clusters in a data set
J. Stat. Softw.
The effect of urban air pollution on inflammation, oxidative stress, coagulation, and autonomic dysfunction in young adults
Am. J. Respir. Crit. Care Med.
Controlled exposure of healthy young volunteers to ozone causes cardiovascular effects
Circulation
Plasma glycine and risk of acute myocardial infarction in patients with suspected stable angina pectoris
J. Am. Heart Assoc.
Diabetes, obesity, and hypertension may enhance associations between air pollution and markers of systemic inflammation
Environ. Health Perspect.
Flexible smoothing with B-splines and penalties. With comments and a rejoinder by the authors
Stat. Sci.
Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance
Diabetes
Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach
Diabetes
Weight-of-evidence evaluation of short-term ozone exposure and cardiovascular effects
Crit. Rev. Toxicol.
Long- and short-term exposure to air pollution and inflammatory/hemostatic markers in midlife women
Epidemiology
Immediate ozone effects on heart rate and repolarisation parameters in potentially susceptible individuals
Occup. Environ. Med.
A guide for a cardiovascular genomics biorepository: the CATHGEN experience
J. Cardiovasc. Transl. Res.
Cited by (51)
Metabolic pathways altered by air pollutant exposure in association with lipid profiles in young adults
2023, Environmental PollutionThe pathophysiological and molecular mechanisms of atmospheric PM<inf>2.5</inf> affecting cardiovascular health: A review
2023, Ecotoxicology and Environmental Safety